How has the microrna market evolved, and where is it heading next?
The microrna market size has grown rapidly in recent years. It will grow from $1.33 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to discovery of microRNAs, RNA interference (RNAi), genome sequencing projects, computational biology and bioinformatics, and extracellular vehicles (EVs) research.
The microrna market size is expected to see rapid growth in the next few years. It will grow to $3.11 billion in 2029 at a compound annual growth rate (CAGR) of 18.5%. The growth in the forecast period can be attributed to clinical translation, regulatory networks and systems biology, microRNA-based therapeutics, therapeutic potential, and biomarker discovery. Major trends in the forecast period include technological advances, bioinformatics and data analysis, cross-species conservation, microbiome interactions, and functional mechanisms.
Get Your Free Sample of The Global MicroRNA Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp
Which major factors have contributed to the expansion of the microrna market?
The increasing number of cancer cases is expected to propel the growth of the microRNA market going forward. Cancer refers to a complex disease characterized by uncontrolled cell growth and proliferation, often leading to the formation of malignant tumors that can invade surrounding tissues and spread to distant organs, posing significant health risks. The increasing number of cancer cases is due to various factors, including aging populations, lifestyle choices such as smoking and poor diet, environmental pollutants, and improved detection methods leading to earlier diagnosis. MicroRNA is combined with traditional cancer therapies to enhance drug sensitivity and improve outcomes. Beyond treatment, miRNAs serve as diagnostic and prognostic biomarkers, helping to identify cancer types, predict disease progression, and monitor treatment responses. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, around 20 million new cases and 9.7 million cancer-related deaths were recorded annually in 2022, and predictions indicate that by 2040, there would be 15.3 million deaths and 29.9 million new cases per year. Therefore, the increasing number of cancer cases is driving the growth of the microRNA market.
How is the microrna market segmented?
The microrna market covered in this report is segmented –
1) By Products: Instruments, Consumables
2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays
3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications
4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations
Subsegments:
1) By Instruments: Qpcr Systems (Quantitative Pcr), Microarray Platforms, Next-Generation Sequencing (Ngs) Systems, Real-Time Pcr Instruments, Microrna Analyzers
2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits), Pcr Reagents, Primers And Probes, Microarrays And Chips, Rna Sequencing Kits
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/microrna-global-market-report
Who are the top competitors in the microrna market?
Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited
Which key trends are expected to influence the microrna market in the coming years?
Major companies operating in the microRNA market are focusing on developing advanced solutions such as MiRNA probe customization services to meet the specific needs of researchers and clinicians, enhance the accuracy of miRNA detection, and facilitate a wide range of applications. MiRNA probe customization services refer to specialized services offered by biotechnology and molecular biology companies to design and produce customized probes specific to particular microRNAs (miRNAs) for various research and clinical applications. For instance, in September 2023, Abnova Corporation, a Taiwan-based biotech company, launched enhanced services for customizing miRNA probes, along with a new range of cataloged miRNA probes, to meet the diverse needs of academic, industrial, and research communities engaged in miRNA research. These probes play a crucial role in identifying and precisely locating miRNAs, which are small, non-coding RNA molecules vital for various biological processes. Abnova’s customization services ensure high specificity and minimal cross-reactivity, making them well-suited for analyzing samples with limited miRNA content.
Which regional trends are influencing the microrna market, and which area dominates the industry?
North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The MicroRNA Market Report 2025 Offer?
The microrna market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
MicroRNAs are small, non-coding RNA molecules, typically about 20-22 nucleotides in length, used to regulate gene expression. They function by binding to complementary sequences on messenger RNA (mRNA) molecules, usually resulting in gene silencing through translational repression or target degradation.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15608
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
